A citation-based method for searching scientific literature

Alexander Drilon, Salvatore Siena, Rafal Dziadziuszko, Fabrice Barlesi, Matthew G Krebs, Alice T Shaw, Filippo de Braud, Christian Rolfo, Myung-Ju Ahn, Jürgen Wolf, Takashi Seto, Byoung Chul Cho, Manish R Patel, Chao-Hua Chiu, Thomas John, Koichi Goto, Christos S Karapetis, Hendrick-Tobias Arkenau, Sang-We Kim, Yuichiro Ohe, Yu-Chung Li, Young K Chae, Christine H Chung, Gregory A Otterson, Haruyasu Murakami, Chia-Chi Lin, Daniel S W Tan, Hans Prenen, Todd Riehl, Edna Chow-Maneval, Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R Wilson, Robert C Doebele. Lancet Oncol 2020
Times Cited: 153



Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo, Brian Turpin, Afshin Dowlati, Marcia S Brose, Leo Mascarenhas, Noah Federman, Jordan Berlin, Wafik S El-Deiry, Christina Baik, John Deeken, Valentina Boni, Ramamoorthy Nagasubramanian, Matthew Taylor, Erin R Rudzinski, Funda Meric-Bernstam, Davendra P S Sohal, Patrick C Ma, Luis E Raez, Jaclyn F Hechtman, Ryma Benayed, Marc Ladanyi, Brian B Tuch, Kevin Ebata, Scott Cruickshank, Nora C Ku, Michael C Cox, Douglas S Hawkins, David S Hong, David M Hyman. N Engl J Med 2018
Times Cited: 1185




List of shared articles



Times cited

Complications following novel therapies for non-small cell lung cancer.
Marcus Skribek, Konstantinos Rounis, Georgios Tsakonas, Simon Ekman. J Intern Med 2022
0

Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.
Suet Kee Loo, Megan E Yates, Sichun Yang, Steffi Oesterreich, Adrian V Lee, Xiao-Song Wang. Genes Chromosomes Cancer 2022
0

Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysis.
Aaron C Tan, Sze Huey Tan, Siqin Zhou, Solange Peters, Giuseppe Curigliano, Daniel S W Tan. Cancer Treat Rev 2022
0

The oncogenic fusion landscape in pediatric CNS neoplasms.
Mieke Roosen, Zelda Odé, Jens Bunt, Marcel Kool. Acta Neuropathol 2022
0

Novel targeted therapies for advanced non-small lung cancer.
Omar Abughanimeh, Anahat Kaur, Badi El Osta, Apar Kishor Ganti. Semin Oncol 2022
0

Entrectinib, a new multi-target inhibitor for cancer therapy.
Qinghua Jiang, Mingxue Li, Hua Li, Lixia Chen. Biomed Pharmacother 2022
1

Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer.
Fiorella Calabrese, Federica Pezzuto, Francesca Lunardi, Francesco Fortarezza, Sofia-Eleni Tzorakoleftheraki, Maria Vittoria Resi, Mariaenrica Tiné, Giulia Pasello, Paul Hofman. Int J Mol Sci 2022
0

Molecular lung cancer: How targeted therapies and personalized medicine are re-defining cancer care.
Zachary L Quinn, Julie A Barta, Jennifer M Johnson. Am J Med Sci 2022
0

NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability.
Hui Wang, Zhi-Wei Li, Qiuxiang Ou, Xue Wu, Misako Nagasaka, Yang Shao, Sai-Hong Ignatius Ou, Yu Yang. Cancer Med 2022
0

Biomarker guided treatment in oncogene-driven advanced non-small cell lung cancer in older adults: A Young International Society of Geriatric Oncology Report.
Konstantinos Christofyllakis, Ana Raquel Monteiro, Onur Cetin, Igor Age Kos, Alastair Greystoke, Andrea Luciani. J Geriatr Oncol 2022
0

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman, Ankit Bharat, Debora S Bruno, Joe Y Chang, Lucian R Chirieac, Thomas A D'Amico,[...]. J Natl Compr Canc Netw 2022
1

Comparison of Alternative Methods to Assess the Cost-Effectiveness of Tumor-Agnostic Therapies: A Triangulation Approach Using Larotrectinib as a Case Study.
Andrew Briggs, Beth Wehler, Jennifer G Gaultney, Alex Upton, Antoine Italiano, Carsten Bokemeyer, Noman Paracha, Sean D Sullivan. Value Health 2022
0

Application of Next Generation Sequencing in Laboratory Medicine.
Yiming Zhong, Feng Xu, Jinhua Wu, Jeffrey Schubert, Marilyn M Li. Ann Lab Med 2021
24

Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer.
Marie-Julie Nokin, Chiara Ambrogio, Ernest Nadal, David Santamaria. Trends Cancer 2021
4

Genomic profiling in non-small-cell lung cancer in young patients. A systematic review.
D Viñal, D Martínez, O Higuera, J de Castro. ESMO Open 2021
6


Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
Nasser H Hanna, Andrew G Robinson, Sarah Temin, Sherman Baker, Julie R Brahmer, Peter M Ellis, Laurie E Gaspar, Rami Y Haddad, Paul J Hesketh, Dharamvir Jain,[...]. J Clin Oncol 2021
64

Systemic Therapy for Mutation-Driven NSCLC.
Lova Sun, Melina E Marmarelis, Corey J Langer. Semin Radiat Oncol 2021
1


Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021
3


Oncogenic driver mutations in non-small cell lung cancer: Past, present and future.
Mathieu Chevallier, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender. World J Clin Oncol 2021
10

Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.
Alexander Drilon, Michael Duruisseaux, Ji-Youn Han, Masaoki Ito, Christina Falcon, Soo-Ryum Yang, Yonina R Murciano-Goroff, Haiquan Chen, Morihito Okada, Miguel Angel Molina,[...]. J Clin Oncol 2021
10

Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.
Kazuhiro Sase, Yasuhito Fujisaka, Masaaki Shoji, Mikio Mukai. Curr Treat Options Oncol 2021
0

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
Michael J Grant, Roy S Herbst, Sarah B Goldberg. Nat Rev Clin Oncol 2021
18


Lung Cancer Stem Cells-Origin, Diagnostic Techniques and Perspective for Therapies.
Agata Raniszewska, Iwona Kwiecień, Elżbieta Rutkowska, Piotr Rzepecki, Joanna Domagała-Kulawik. Cancers (Basel) 2021
4

Lung cancer.
Alesha A Thai, Benjamin J Solomon, Lecia V Sequist, Justin F Gainor, Rebecca S Heist. Lancet 2021
81


Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers.
Noura J Choudhury, Jaime L Schneider, Tejas Patil, Viola W Zhu, Debra A Goldman, Soo-Ryum Yang, Christina J Falcon, Andrew Do, Yunan Nie, Andrew J Plodkowski,[...]. JTO Clin Res Rep 2021
3